OTCMKTS:CGNH

CardioGenics (CGNH) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
CGNH stock logo

About CardioGenics Stock (OTCMKTS:CGNH)

CardioGenics Holdings Inc. engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market in the United States, Canada, Europe, and internationally. Its products include QL Care Analyzer, a portable, stand-alone, and automated point-of-care (POC) immunoassay analyzer that uses a proprietary self-metering cartridge to perform immunoassay tests at the POC; a series of immunoassay tests to identify cardiac markers in the blood at the time of a heart attack; and paramagnetic beads that are used as solid surfaces in heterogeneous immunoassay tests by clinical and research laboratories. The company was formerly known as Jag Media Holdings, Inc. and changed its name to CardioGenics Holdings Inc. in 2009. The company was founded in 1997 and is headquartered in Mississauga, Canada.

CGNH Stock News Headlines

“Retirement Secret” Showed 995% Gain Last Time We Shared It
Central Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.
Cardiogenics Holdings Inc (CGNH)
“Retirement Secret” Showed 995% Gain Last Time We Shared It
Central Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.
CardioGenics Holdings Inc.
See More Headlines
Receive CGNH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CardioGenics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/26/2024
Fiscal Year End
10/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Business services, not elsewhere classified
Sub-Industry
N/A
Current Symbol
OTCMKTS:CGNH
Employees
4
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Dr. Yahia Abdul Gawad (Age 66)
    Founder, CEO & Director
    Comp: $119.45k
  • Mr. James A. Essex CA (Age 75)
    MBA, Chief Financial Officer
    Comp: $28.67k
  • Ms. Linda J. Sterling F.Inst.L.C.O. (Age 63)
    Corporate Secretary & Director

CGNH Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of CardioGenics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CardioGenics investors own include Trinity Biotech (TRIB), Rock Creek Pharmaceuticals (RCPIQ),

How do I buy shares of CardioGenics?

Shares of CGNH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:CGNH) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners